Image Donation

Image Donation

Menu

Home >
News

Institut Curie News

Discover the latest news from Institut Curie.

Highlights

Research

Relapses of breast cancer: discovery of a key cellular resistance mechanism

06/11/2025

Congress

ESMO 2025 - Metastatic uveal melanoma: a promising new treatment combination

18/10/2025

Congress

ESMO 2025 : Finding Less Toxic Treatments for Women with Hormone-Dependent Breast Cancer

17/10/2025

Search

Filter

Filter

Publication date

Fields

Search

217 result(s)

Innovation
Dr. Elliot Thouvenot, i-PhD winner for the Kyma Biotech project: toward a new start-up from Institut Curie
06/11/2025
Research
Relapses of breast cancer: discovery of a key cellular resistance mechanism
06/11/2025
Research
AI: Prof. Thomas Walter’s team shines at the MIDOG 2025 mitosis detection challenge
30/10/2025
Congress
ESMO 2025 - Metastatic uveal melanoma: a promising new treatment combination
18/10/2025
Congress
ESMO 2025 : Finding Less Toxic Treatments for Women with Hormone-Dependent Breast Cancer
17/10/2025
Congress
ESMO 2025: Institut Curie at the forefront of innovation against cancers
16/10/2025
Innovation
Institut Curie and PariSanté Campus sign a strategic partnership to accelerate digital innovation in health
14/10/2025
Research
Cell division: how an epigenetic modification protects our chromosomes
04/09/2025
Turquoise September
Institut Curie mobilizes to prevent, understand and treat gynecological cancers
04/09/2025
Golden September
At Institut Curie, life goes on during treatment for children and their families
01/09/2025
Innovation
A key enzyme in the fight against resistant female cancers: Dr. Raphaël Ceccaldi’s project receives award
26/08/2025
Research
Breast cancer in elderly women: the ASTER 70s study evaluates the usefulness of adjuvant chemotherapy
01/08/2025
Innovation
Abivax’s molecule, developed at Institut Curie, achieves clinical success and secures historic fundraising
01/08/2025
Research
A human protein inherited from bacteria reveals an overlooked aspect of human immunity
25/07/2025
Innovation
One Biosciences, a spin-off from Institut Curie, raises €15 million to revolutionize precision medicine
17/07/2025
Institutional
For a World Without Incurable Cancers: Institut Curie’s 2024 Annual Report Boldly Reaffirms Its Ambition
17/07/2025
Award
Congratulations to Dr. Leïla Perié, recipient of an ERC Proof of Concept Grant
15/07/2025
Institutional
Isabelle Henry, appointed as a new member of the Executive Board
10/07/2025
Award
Dr. Julien Robert-Paganin receives the CNRS Bronze Medal 2025
09/07/2025
Innovation
When proton therapy meets aerospace: Institut Curie pushes the boundaries of innovation to simulate the space environment
12/06/2025
Research
Centromeres, unexpected players in immunity
05/06/2025
Innovation
Ergobass: a field-inspired innovation “made in Curie” to improve patient care
04/06/2025
ASCO
Lung Cancer: Preoperative Immunotherapy Improves Patient Survival
02/06/2025
ASCO
Promising new targeted therapy in very rare pediatric cancers
01/06/2025
ASCO
Liquid biopsies: a revolutionary approach to treatment resistance in hormone-dependent metastatic breast cancer
01/06/2025
ASCO
ASCO Conference 2025: A Landmark Year for Institut Curie
28/05/2025
Advances in Neuroblastoma Research Meeting
Pediatric cancers: how Institut Curie is advancing neuroblastoma research
26/05/2025
Research
Spatial transcriptomics: a new guide to better study the spatiality of cells in tissues
20/05/2025
Award
Congratulations to Dr. Joshua Waterfall, recipient of the Arceci Innovation Award
15/05/2025
Innovation
A new class of molecules against cancer cells refractory to standard treatments
07/05/2025